9 Recruiting Chronic Lymphocytic Leukemia Clinical Trials in Ohio
Explore active chronic lymphocytic leukemia research studies enrolling across Ohio. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Chronic Lymphocytic Leukemia Studies in Ohio
🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia
📍 Research Site — Columbus, Ohio
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
📍 University of Cincinnati — Cincinnati, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔